Top

A -- Liposuction Cannula Apparatus

Active

Reference-Number-FBO02-005-292Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

The Lawrence Livermore National Laboratory (LLNL), managed by the University of California under the U.S. Department of Energy, is seeking partnerships with industry to commercialize an innovative liposuction cannula device. This device features a reciprocating liposuction cannula with a single cutting shaft that can employ a combination of reciprocating and ultrasonic energy, along with the use of excess vacuum capacity, to facilitate the cannula’s motion. Designed for improved efficiency, one version offers a non-rectilinear oscillation motion, incorporating an additional lumen to aid in cooling the cannula tip, balancing pressure, or easing the movement of fat during the procedure. The combination of energy types enables reduced energy consumption, and the design eliminates the need for protective monitoring measures to prevent tissue penetration, ensuring safer operation. The device is co-owned with two other entities, separate from LLNL, and the laboratory is inviting companies interested in commercializing or further developing this technology to submit written statements of interest within 30 days of the announcement. These statements should outline a commercialization plan and detail relevant corporate capabilities. This solicitation is not a procurement, but rather a request for expressions of interest to facilitate partnerships. Responses should be addressed to LLNL’s Industrial Partnerships and Commercialization office, with a specific reference number provided, to enable LLNL to consider the proposed industrial collaborations for this advanced medical technology.

General Info

LLNL seeks industry partners to commercialize innovative liposuction cannula using ultrasonic, reciprocating energy.

Agency

N/A

NAICS

339113 - Surgical Appliance and Supplies Manufacturing

Place of Performance

Not specified

Set-Aside

NONE

Documents

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PostedMar 1

special-notice

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

AgencyN/A

ContactsNo contacts available

OfficeN/A

Organization / Agency

N/A

Office AddressN/A

ContactsNo contact information available

Full Description

LAWRENCE LIVERMORE NATIONAL LABORATORY SEEKS PARTNERSHIPS WITH INDUSTRY TO COMMERCIALIZE LLNL'S LIPOSUCTION DEVICE Announcement: The Lawrence Livermore National Laboratory (LLNL), operated by the University of California under contract with the U.S. Department of Energy is seeking industrial partners to commercialize a liposuction device. The reciprocating liposuction cannula device utilizes a single cutting shaft, may utilize a combination of reciprocating energy and ultrasonic energy, and may utilize available excess vacuum capacity to produce the reciprocation of the cannula shaft. One embodiment of the device uses a single shaft for cutting, preferably in a non-rectilinear oscillation motion. An additional lumen may be utilized for cooling of the cannula tip, equilibrating the pressure, or providing additional pressure to allow fat to move back up the cannula shaft with greater ease. The combination of reciprocating energy and ultrasonic energy reduces the total energy required of each type. Also, in this non-rectilinear reciprocating form of the liposuction cannula device, no protective measures (e.g., monitoring tip), need be taken in order to prevent the device from penetrating through important tissues. This invention is co-owned with two other entities, not related to the Lawrence Livermore National Laboratory. If you are interesed in working with LLNL to commercialize or further develop the Liposuction device described above, please respond in writing within 30 days of this announcement. Note: THIS IS NOT A PROCUREMENT. Companies interested in commercializing LLNL's Liposuction Device should provide a written statement of interest including a commercialization plan and a description of corporate capabilities relevant to commercializing the technology. Written responses should be directed to: Lawrence Livermore National Laboratory Industrial Partnerships and Commercialization P.O. Box 808, L-795 Livermore, CA 94551-0808 Attention: FBO02-005-292. Please provide your written statement within thirty (30) days from the date this announcement is posted to ensure consideration of your interest in LLNL's Liposuction Device.